Heparin reduces overcirculation-induced pulmonary artery remodeling through P38 MAPK in piglet

Annals of Thoracic Surgery

Volumn 99, Issue 5, 2015, Pages 1677-1684

  Zhao, Gaofeng ^a,b   Seng, Jingjing ^a,b   Beagle, John ^a   Syrkina, Olga ^a   Hales, Charles A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA FIBROBLAST GROWTH FACTOR; CYCLINE; FIBROBLAST GROWTH FACTOR; HEPARIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PLACEBO; PLATELET DERIVED GROWTH FACTOR; PROTEIN P27; UNCLASSIFIED DRUG; VASCULOTROPIN; FIBRINOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTERY ANASTOMOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART RATE; HEART VENTRICLE SEPTUM; HEMATOCRIT; HEMODYNAMICS; HEPARINIZATION; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; NONHUMAN; PH; PIGLET; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY REMODELING; PULMONARY HYPERTENSION; THORAX SURGERY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; CULTURE TECHNIQUE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; HYPERTENSION, PULMONARY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PIG; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HEPARIN; HYPERTENSION, PULMONARY; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY ARTERY; SWINE; VASCULAR REMODELING;

EID: 84929501757     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.12.061     Document Type: Article

References (20)

1. D.A. Goncharov, T.V. Kudryashova, and H. Ziai Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension Circulation 129 2014 864 874
2. C.V. Garat, J.T. Crossno, T.M. Sullivan, J.E. Reusch, and D.J. Klemm Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells J Cardiovasc Pharmacol 62 2013 539 548
3. Y. Makiyama, K. Toba, and K. Kato Imatinib mesylate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury Tohoku J Exp Med 215 2008 299 306
4. E. Al-Ansari, H.K. Du, and L. Yu Low-molecular-weight heparin inhibits hypoxic pulmonary hypertension and vascular remodeling in guinea pigs Chest 132 2007 1898 1905
5. L. Yu, D.A. Quinn, H.G. Garg, and C.A. Hales Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice Circ Res 97 2005 937 945
6. J.F. Deux, A. Meddahi-Pellé, F. Bree, I. Bataille, J.B. Michel, and D. Letourneur Comparative studies on the mechanisms of action of four polysaccharides on arterial restenosis J Biomater Sci Polym Ed 20 2009 689 702
7. M. Dufresne, and R. Warocquier-Clérout Explants of porcine coronary artery in culture: a paradigm for studying the influence of heparin on vascular wall cell proliferation Cytotechnology 37 2001 13 22
8. O. Honjo, S.L. Merklinger, and J.B. Poe Mechanical cavopulmonary assist maintains pulmonary and cerebral blood flow in a piglet model of a bidirectional cavopulmonary shunt with high pulmonary vascular resistance J Thorac Cardiovasc Surg 137 2009 355 361
9. M. Ricci, P. Lombardi, A. Galindo, S. Schultz, A. Vasquez, and E. Rosenkranz Effects of single-ventricle physiology with aortopulmonary shunt on regional myocardial blood flow in a piglet model J Thorac Cardiovasc Surg 132 2006 252 259
10. B. Rondelet, F. Kerbaul, and R. Van Beneden Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 289 2005 2319 2324
11. M. Ceccarelli, D. Bani, and L. Cinci Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy J Cell Mol Med 13 2009 2704 2712
12. L.P. Brewster, E.M. Brey, and A.K. Tassiopoulos Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM) Am J Surg 188 2004 575 579
13. H. Yu, M.C. Clarke, N. Figg, T.D. Littlewood, and M.R. Bennett Smooth muscle cell apoptosis promotes vessel remodeling and repair via activation of cell migration, proliferation, and collagen synthesis Arterioscler Thromb Vasc Biol 31 2011 2402 2409
14. J. Tan, D. Liu, and X. Lv MAPK mediates inflammatory response and cell death in rat pulmonary microvascular endothelial cells in an ischemia-reperfusion model of lung transplantation J Heart Lung Transplant 32 2013 823 831
15. Y.P. Au, R.D. Kenagy, M.M. Lowes, and A.W. Clowes Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration Haemostasis 23 1993 177 182
16. S. Hibino, M. Shibuya, and M.P. Hoffman Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44 Cancer Res 65 2005 10494 10501
17. W. Ariyoshi, T. Takahashi, and T. Kanno Heparin inhibits osteoclastic differentiation and function J Cell Biochem 103 2008 1707 1717
18. A. Relini, S. De Stefano, and S. Torrassa Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen J Biol Chem 283 2008 4912 4920
19. A. Kalmes, B.R. Vesti, G. Daum, J.A. Abraham, and A.W. Clowes Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor Circ Res 87 2000 92 98
20. G. Zhao, R.S. Shaik, H. Zhao, J. Beagle, S. Kuo, and C.A. Hales Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expression J Vasc Surg 53 2011 1359 1367